MoneyWorks4Me

Wanbury informs about change in management

18 Nov 2023 Evaluate
Wanbury has informed that based on the approval of the members of the Company in the Extra-Ordinary General Meeting held today, Saturday 18th November, 2023 have approved the following: Appointment of Pravin Dilip Pawar (DIN: 10356479) as the Non-Executive Independent Director of the Company for a term of one year with effective from November 18, 2023 to November 17, 2024. The relevant details as per the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIRJCFD/CMD/ 4/2015 dated September 09, 2015, are given in the enclosed Annexure-I.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..